CA3027999A1 - Mhc-e restricted epitopes, binding molecules and related methods and uses - Google Patents

Info

Publication number

CA3027999A1

CA3027999A1 CA3027999A CA3027999A CA3027999A1 CA 3027999 A1 CA3027999 A1 CA 3027999A1 CA 3027999 A CA3027999 A CA 3027999A CA 3027999 A CA3027999 A CA 3027999A CA 3027999 A1 CA3027999 A1 CA 3027999A1

Authority

CA

Canada

Prior art keywords

mhc

molecule

antigen

peptide

cell

Prior art date

2016-06-27

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 230000027455 binding Effects 0.000 title claims abstract description 389
• 238000009739 binding Methods 0.000 title claims abstract description 386
• 238000000034 method Methods 0.000 title claims abstract description 340
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 782
• 108091007433 antigens Proteins 0.000 claims abstract description 452
• 102000036639 antigens Human genes 0.000 claims abstract description 452
• 239000000427 antigen Substances 0.000 claims abstract description 441
• 210000004027 cell Anatomy 0.000 claims abstract description 440
• 108091008874 T cell receptors Proteins 0.000 claims abstract description 221
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims abstract description 221
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 93
• 239000012634 fragment Substances 0.000 claims abstract description 91
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims abstract description 20
• 230000001717 pathogenic effect Effects 0.000 claims abstract description 17
• 239000000203 mixture Substances 0.000 claims abstract description 16
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 271
• 150000007523 nucleic acids Chemical class 0.000 claims description 113
• 102000039446 nucleic acids Human genes 0.000 claims description 112
• 108020004707 nucleic acids Proteins 0.000 claims description 112
• 108090000623 proteins and genes Proteins 0.000 claims description 101
• 150000001413 amino acids Chemical class 0.000 claims description 80
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims description 70
• 108010075704 HLA-A Antigens Proteins 0.000 claims description 69
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 59
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 54
• 230000014509 gene expression Effects 0.000 claims description 53
• 241000282414 Homo sapiens Species 0.000 claims description 50
• 102000004169 proteins and genes Human genes 0.000 claims description 47
• 230000003612 virological effect Effects 0.000 claims description 45
• 230000028993 immune response Effects 0.000 claims description 43
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims description 41
• -1 MN-CA IX Proteins 0.000 claims description 35
• 239000004055 small Interfering RNA Substances 0.000 claims description 34
• 108020004635 Complementary DNA Proteins 0.000 claims description 30
• 238000010804 cDNA synthesis Methods 0.000 claims description 30
• 239000002299 complementary DNA Substances 0.000 claims description 30
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 claims description 26
• 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 claims description 25
• 201000011510 cancer Diseases 0.000 claims description 24
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 22
• 108020004414 DNA Proteins 0.000 claims description 22
• 239000003795 chemical substances by application Substances 0.000 claims description 22
• 230000004044 response Effects 0.000 claims description 22
• 230000005867 T cell response Effects 0.000 claims description 21
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 21
• 102000053602 DNA Human genes 0.000 claims description 20
• 108091027967 Small hairpin RNA Proteins 0.000 claims description 20
• 108020004459 Small interfering RNA Proteins 0.000 claims description 20
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 18
• 201000010099 disease Diseases 0.000 claims description 18
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
• 101710163270 Nuclease Proteins 0.000 claims description 17
• 230000003213 activating effect Effects 0.000 claims description 17
• 241000701022 Cytomegalovirus Species 0.000 claims description 15
• 108010058607 HLA-B Antigens Proteins 0.000 claims description 15
• 230000002452 interceptive effect Effects 0.000 claims description 15
• 102000004127 Cytokines Human genes 0.000 claims description 14
• 108090000695 Cytokines Proteins 0.000 claims description 14
• 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 claims description 14
• 241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 14
• 239000002269 analeptic agent Substances 0.000 claims description 14
• 230000002401 inhibitory effect Effects 0.000 claims description 14
• 102000005962 receptors Human genes 0.000 claims description 14
• 108020003175 receptors Proteins 0.000 claims description 14
• 230000004936 stimulating effect Effects 0.000 claims description 13
• 241000701806 Human papillomavirus Species 0.000 claims description 12
• 241000700605 Viruses Species 0.000 claims description 12
• 230000035772 mutation Effects 0.000 claims description 12
• 108091033409 CRISPR Proteins 0.000 claims description 11
• 238000000338 in vitro Methods 0.000 claims description 11
• 230000001939 inductive effect Effects 0.000 claims description 11
• 238000012360 testing method Methods 0.000 claims description 11
• 108010074328 Interferon-gamma Proteins 0.000 claims description 10
• 102000008070 Interferon-gamma Human genes 0.000 claims description 10
• 208000002672 hepatitis B Diseases 0.000 claims description 10
• 230000002163 immunogen Effects 0.000 claims description 10
• 229960003130 interferon gamma Drugs 0.000 claims description 10
• 108091026890 Coding region Proteins 0.000 claims description 9
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 9
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 9
• 108010026331 alpha-Fetoproteins Proteins 0.000 claims description 9
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 9
• 230000001580 bacterial effect Effects 0.000 claims description 9
• 108010052199 HLA-C Antigens Proteins 0.000 claims description 8
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 claims description 8
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 claims description 8
• 241001502974 Human gammaherpesvirus 8 Species 0.000 claims description 8
• 108010017070 Zinc Finger Nucleases Proteins 0.000 claims description 8
• 239000002243 precursor Substances 0.000 claims description 8
• 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 claims description 8
• 102000006306 Antigen Receptors Human genes 0.000 claims description 7
• 108010083359 Antigen Receptors Proteins 0.000 claims description 7
• 206010009944 Colon cancer Diseases 0.000 claims description 7
• 241000711549 Hepacivirus C Species 0.000 claims description 7
• 108700011259 MicroRNAs Proteins 0.000 claims description 7
• 239000002253 acid Substances 0.000 claims description 7
• 239000002679 microRNA Substances 0.000 claims description 7
• 238000012163 sequencing technique Methods 0.000 claims description 7
• 238000011830 transgenic mouse model Methods 0.000 claims description 7
• 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims description 6
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 claims description 6
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims description 6
• 102100031413 L-dopachrome tautomerase Human genes 0.000 claims description 6
• 108010072866 Prostate-Specific Antigen Proteins 0.000 claims description 6
• 102100038358 Prostate-specific antigen Human genes 0.000 claims description 6
• 102100035703 Prostatic acid phosphatase Human genes 0.000 claims description 6
• 238000004587 chromatography analysis Methods 0.000 claims description 6
• 108010051081 dopachrome isomerase Proteins 0.000 claims description 6
• 238000010362 genome editing Methods 0.000 claims description 6
• 238000001114 immunoprecipitation Methods 0.000 claims description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
• 239000002245 particle Substances 0.000 claims description 6
• 108010043671 prostatic acid phosphatase Proteins 0.000 claims description 6
• 108010014402 tyrosinase-related protein-1 Proteins 0.000 claims description 6
• 108010087819 Fc receptors Proteins 0.000 claims description 5
• 102000009109 Fc receptors Human genes 0.000 claims description 5
• 241000341655 Human papillomavirus type 16 Species 0.000 claims description 5
• 206010033128 Ovarian cancer Diseases 0.000 claims description 5
• 206010060862 Prostate cancer Diseases 0.000 claims description 5
• 108010034949 Thyroglobulin Proteins 0.000 claims description 5
• 102000009843 Thyroglobulin Human genes 0.000 claims description 5
• 239000006166 lysate Substances 0.000 claims description 5
• 201000001441 melanoma Diseases 0.000 claims description 5
• 229960002175 thyroglobulin Drugs 0.000 claims description 5
• 206010006187 Breast cancer Diseases 0.000 claims description 4
• 208000026310 Breast neoplasm Diseases 0.000 claims description 4
• 206010018338 Glioma Diseases 0.000 claims description 4
• 101710192602 Latent membrane protein 1 Proteins 0.000 claims description 4
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 4
• 241000283984 Rodentia Species 0.000 claims description 4
• 206010039491 Sarcoma Diseases 0.000 claims description 4
• 210000004369 blood Anatomy 0.000 claims description 4
• 239000008280 blood Substances 0.000 claims description 4
• 210000004443 dendritic cell Anatomy 0.000 claims description 4
• 238000010494 dissociation reaction Methods 0.000 claims description 4
• 230000005593 dissociations Effects 0.000 claims description 4
• 210000002950 fibroblast Anatomy 0.000 claims description 4
• 208000014829 head and neck neoplasm Diseases 0.000 claims description 4
• 208000005252 hepatitis A Diseases 0.000 claims description 4
• 210000005260 human cell Anatomy 0.000 claims description 4
• 230000001965 increasing effect Effects 0.000 claims description 4
• 210000004072 lung Anatomy 0.000 claims description 4
• 210000002540 macrophage Anatomy 0.000 claims description 4
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
• 239000008194 pharmaceutical composition Substances 0.000 claims description 4
• 201000001514 prostate carcinoma Diseases 0.000 claims description 4
• 230000002829 reductive effect Effects 0.000 claims description 4
• SSOORFWOBGFTHL-OTEJMHTDSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SSOORFWOBGFTHL-OTEJMHTDSA-N 0.000 claims description 3
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 3
• HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims description 3
• WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims description 3
• 102100035526 B melanoma antigen 1 Human genes 0.000 claims description 3
• 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 3
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 3
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 3
• 101001029175 Bacillus subtilis (strain 168) Intracellular iron chaperone frataxin Proteins 0.000 claims description 3
• 102100032912 CD44 antigen Human genes 0.000 claims description 3
• 102100025222 CD63 antigen Human genes 0.000 claims description 3
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims description 3
• 101710132601 Capsid protein Proteins 0.000 claims description 3
• 108010051152 Carboxylesterase Proteins 0.000 claims description 3
• 102000013392 Carboxylesterase Human genes 0.000 claims description 3
• 108090000538 Caspase-8 Proteins 0.000 claims description 3
• 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 3
• 108050006400 Cyclin Proteins 0.000 claims description 3
• 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 claims description 3
• 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 claims description 3
• 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 claims description 3
• 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 claims description 3
• 101150084967 EPCAM gene Proteins 0.000 claims description 3
• 108010044090 Ephrin-B2 Proteins 0.000 claims description 3
• 101710122228 Epstein-Barr nuclear antigen 2 Proteins 0.000 claims description 3
• 101710122231 Epstein-Barr nuclear antigen 3 Proteins 0.000 claims description 3
• 101710122233 Epstein-Barr nuclear antigen 4 Proteins 0.000 claims description 3
• 101710122229 Epstein-Barr nuclear antigen 6 Proteins 0.000 claims description 3
• 102100038595 Estrogen receptor Human genes 0.000 claims description 3
• 102100039717 G antigen 1 Human genes 0.000 claims description 3
• 208000032612 Glial tumor Diseases 0.000 claims description 3
• 229930186217 Glycolipid Natural products 0.000 claims description 3
• 206010057212 Hepatitis viral infections Diseases 0.000 claims description 3
• 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 claims description 3
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 3
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 3
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 3
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 3
• 101000934368 Homo sapiens CD63 antigen Proteins 0.000 claims description 3
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims description 3
• 101000886137 Homo sapiens G antigen 1 Proteins 0.000 claims description 3
• 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 3
• 101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 claims description 3
• 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims description 3
• 101001036406 Homo sapiens Melanoma-associated antigen C1 Proteins 0.000 claims description 3
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims description 3
• 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims description 3
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 3
• 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 3
• 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims description 3
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 3
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims description 3
• 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims description 3
• 101000955067 Homo sapiens WAP four-disulfide core domain protein 2 Proteins 0.000 claims description 3
• 108010031794 IGF Type 1 Receptor Proteins 0.000 claims description 3
• 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 3
• 108090001061 Insulin Proteins 0.000 claims description 3
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 claims description 3
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims description 3
• 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims description 3
• 102000001399 Kallikrein Human genes 0.000 claims description 3
• 108060005987 Kallikrein Proteins 0.000 claims description 3
• 108010028275 Leukocyte Elastase Proteins 0.000 claims description 3
• 102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 claims description 3
• 102000017274 MDM4 Human genes 0.000 claims description 3
• 108050005300 MDM4 Proteins 0.000 claims description 3
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 3
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims description 3
• 102100039447 Melanoma-associated antigen C1 Human genes 0.000 claims description 3
• 102000051089 Melanotransferrin Human genes 0.000 claims description 3
• 108700038051 Melanotransferrin Proteins 0.000 claims description 3
• 108010052285 Membrane Proteins Proteins 0.000 claims description 3
• 102000003735 Mesothelin Human genes 0.000 claims description 3
• 108090000015 Mesothelin Proteins 0.000 claims description 3
• 102100034256 Mucin-1 Human genes 0.000 claims description 3
• 102100023123 Mucin-16 Human genes 0.000 claims description 3
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 3
• 102100033174 Neutrophil elastase Human genes 0.000 claims description 3
• 108010051791 Nuclear Antigens Proteins 0.000 claims description 3
• 102000019040 Nuclear Antigens Human genes 0.000 claims description 3
• 102100040120 Prominin-1 Human genes 0.000 claims description 3
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 3
• 206010038389 Renal cancer Diseases 0.000 claims description 3
• 208000006265 Renal cell carcinoma Diseases 0.000 claims description 3
• 102100038081 Signal transducer CD24 Human genes 0.000 claims description 3
• 101800001271 Surface protein Proteins 0.000 claims description 3
• 108010017842 Telomerase Proteins 0.000 claims description 3
• 102000003425 Tyrosinase Human genes 0.000 claims description 3
• 108060008724 Tyrosinase Proteins 0.000 claims description 3
• 102100031358 Urokinase-type plasminogen activator Human genes 0.000 claims description 3
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims description 3
• 102000013532 Uroplakin II Human genes 0.000 claims description 3
• 108010065940 Uroplakin II Proteins 0.000 claims description 3
• 102000013127 Vimentin Human genes 0.000 claims description 3
• 108010065472 Vimentin Proteins 0.000 claims description 3
• 201000008275 breast carcinoma Diseases 0.000 claims description 3
• 201000010989 colorectal carcinoma Diseases 0.000 claims description 3
• 230000000139 costimulatory effect Effects 0.000 claims description 3
• 108010038795 estrogen receptors Proteins 0.000 claims description 3
• 208000021045 exocrine pancreatic carcinoma Diseases 0.000 claims description 3
• 239000003102 growth factor Substances 0.000 claims description 3
• 229940084986 human chorionic gonadotropin Drugs 0.000 claims description 3
• 230000003053 immunization Effects 0.000 claims description 3
• 229940125396 insulin Drugs 0.000 claims description 3
• 230000000968 intestinal effect Effects 0.000 claims description 3
• 201000005296 lung carcinoma Diseases 0.000 claims description 3
• 238000002823 phage display Methods 0.000 claims description 3
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 3
• 102000003998 progesterone receptors Human genes 0.000 claims description 3
• 108090000468 progesterone receptors Proteins 0.000 claims description 3
• 201000010174 renal carcinoma Diseases 0.000 claims description 3
• 210000000952 spleen Anatomy 0.000 claims description 3
• 206010041823 squamous cell carcinoma Diseases 0.000 claims description 3
• 210000005048 vimentin Anatomy 0.000 claims description 3
• 101100395313 Homo sapiens HLA-E gene Proteins 0.000 claims description 2
• 101000880770 Homo sapiens Protein SSX2 Proteins 0.000 claims description 2
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 claims description 2
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 claims description 2
• 102100037686 Protein SSX2 Human genes 0.000 claims description 2
• 108010032166 TARP Proteins 0.000 claims description 2
• 108010073062 Transcription Activator-Like Effectors Proteins 0.000 claims description 2
• 210000001185 bone marrow Anatomy 0.000 claims description 2
• 210000002798 bone marrow cell Anatomy 0.000 claims description 2
• 238000002824 mRNA display Methods 0.000 claims description 2
• 230000001404 mediated effect Effects 0.000 claims description 2
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
• 238000002702 ribosome display Methods 0.000 claims description 2
• 230000003381 solubilizing effect Effects 0.000 claims description 2
• 210000004988 splenocyte Anatomy 0.000 claims description 2
• 102000013529 alpha-Fetoproteins Human genes 0.000 claims 3
• 102000004091 Caspase-8 Human genes 0.000 claims 1
• 102000016736 Cyclin Human genes 0.000 claims 1
• 102000006396 Ephrin-B2 Human genes 0.000 claims 1
• 102100023915 Insulin Human genes 0.000 claims 1
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 claims 1
• 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract description 173
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract description 172
• 238000011467 adoptive cell therapy Methods 0.000 abstract description 5
• 230000001363 autoimmune Effects 0.000 abstract description 5
• 235000001014 amino acid Nutrition 0.000 description 66
• 229940024606 amino acid Drugs 0.000 description 66
• 108700028369 Alleles Proteins 0.000 description 46
• 235000018102 proteins Nutrition 0.000 description 41
• 125000003729 nucleotide group Chemical group 0.000 description 39
• 229920002477 rna polymer Polymers 0.000 description 36
• 239000002773 nucleotide Substances 0.000 description 34
• 238000003556 assay Methods 0.000 description 33
• 108091054437 MHC class I family Proteins 0.000 description 31
• 102000043129 MHC class I family Human genes 0.000 description 30
• 239000013604 expression vector Substances 0.000 description 28
• 239000013598 vector Substances 0.000 description 27
• 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 description 23
• 229920001184 polypeptide Polymers 0.000 description 21
• 230000000875 corresponding effect Effects 0.000 description 20
• 230000002950 deficient Effects 0.000 description 17
• 108091054438 MHC class II family Proteins 0.000 description 13
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 13
• 230000000694 effects Effects 0.000 description 13
• 230000009257 reactivity Effects 0.000 description 13
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 12
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 12
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 12
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 12
• 125000003275 alpha amino acid group Chemical group 0.000 description 12
• 230000009368 gene silencing by RNA Effects 0.000 description 12
• 239000000523 sample Substances 0.000 description 12
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 11
• 230000000295 complement effect Effects 0.000 description 11
• 238000012216 screening Methods 0.000 description 11
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 10
• 101710185494 Zinc finger protein Proteins 0.000 description 10
• 102100023597 Zinc finger protein 816 Human genes 0.000 description 10
• 238000013459 approach Methods 0.000 description 10
• 239000003153 chemical reaction reagent Substances 0.000 description 10
• 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 10
• 238000012545 processing Methods 0.000 description 10
• 229910052725 zinc Inorganic materials 0.000 description 10
• 239000011701 zinc Substances 0.000 description 10
• 108020005004 Guide RNA Proteins 0.000 description 9
• 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 9
• 108010024164 HLA-G Antigens Proteins 0.000 description 9
• 108700026244 Open Reading Frames Proteins 0.000 description 9
• 230000000890 antigenic effect Effects 0.000 description 9
• 238000003114 enzyme-linked immunosorbent spot assay Methods 0.000 description 9
• 230000003993 interaction Effects 0.000 description 9
• 239000003446 ligand Substances 0.000 description 9
• 241000894007 species Species 0.000 description 9
• 241000699666 Mus <mouse, genus> Species 0.000 description 8
• 238000003752 polymerase chain reaction Methods 0.000 description 8
• 210000001519 tissue Anatomy 0.000 description 8
• 108010088729 HLA-A*02:01 antigen Proteins 0.000 description 7
• 108060003951 Immunoglobulin Proteins 0.000 description 7
• 108091028043 Nucleic acid sequence Proteins 0.000 description 7
• 230000003321 amplification Effects 0.000 description 7
• 235000018417 cysteine Nutrition 0.000 description 7
• 102000018358 immunoglobulin Human genes 0.000 description 7
• 238000003199 nucleic acid amplification method Methods 0.000 description 7
• 230000000638 stimulation Effects 0.000 description 7
• 102100023635 Alpha-fetoprotein Human genes 0.000 description 6
• 208000023275 Autoimmune disease Diseases 0.000 description 6
• 108010074032 HLA-A2 Antigen Proteins 0.000 description 6
• 102000025850 HLA-A2 Antigen Human genes 0.000 description 6
• 101000986084 Homo sapiens HLA class I histocompatibility antigen, C alpha chain Proteins 0.000 description 6
• 108010002350 Interleukin-2 Proteins 0.000 description 6
• 108010067902 Peptide Library Proteins 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 238000000684 flow cytometry Methods 0.000 description 6
• 230000003834 intracellular effect Effects 0.000 description 6
• 238000010561 standard procedure Methods 0.000 description 6
• 238000013518 transcription Methods 0.000 description 6
• 102000043131 MHC class II family Human genes 0.000 description 5
• 108020004511 Recombinant DNA Proteins 0.000 description 5
• 108010081734 Ribonucleoproteins Proteins 0.000 description 5
• 102000004389 Ribonucleoproteins Human genes 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 238000004458 analytical method Methods 0.000 description 5
• 230000030741 antigen processing and presentation Effects 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 238000006471 dimerization reaction Methods 0.000 description 5
• 238000010828 elution Methods 0.000 description 5
• 239000000833 heterodimer Substances 0.000 description 5
• 239000013612 plasmid Substances 0.000 description 5
• 238000000746 purification Methods 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 230000011664 signaling Effects 0.000 description 5
• 230000008685 targeting Effects 0.000 description 5
• 230000001225 therapeutic effect Effects 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• 210000004881 tumor cell Anatomy 0.000 description 5
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• 101800001357 Potential peptide Proteins 0.000 description 4
• 102400000745 Potential peptide Human genes 0.000 description 4
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
• 230000000692 anti-sense effect Effects 0.000 description 4
• 210000005220 cytoplasmic tail Anatomy 0.000 description 4
• 238000013461 design Methods 0.000 description 4
• 238000001514 detection method Methods 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• 238000004128 high performance liquid chromatography Methods 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 238000002955 isolation Methods 0.000 description 4
• 230000000670 limiting effect Effects 0.000 description 4
• 238000004949 mass spectrometry Methods 0.000 description 4
• 239000012528 membrane Substances 0.000 description 4
• 210000004379 membrane Anatomy 0.000 description 4
• 108020004999 messenger RNA Proteins 0.000 description 4
• 238000012544 monitoring process Methods 0.000 description 4
• 231100000590 oncogenic Toxicity 0.000 description 4
• 230000002246 oncogenic effect Effects 0.000 description 4
• 238000000159 protein binding assay Methods 0.000 description 4
• 230000000754 repressing effect Effects 0.000 description 4
• 230000001177 retroviral effect Effects 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 238000001890 transfection Methods 0.000 description 4
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 3
• 101150076489 B gene Proteins 0.000 description 3
• 101150111062 C gene Proteins 0.000 description 3
• 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 description 3
• 102000052510 DNA-Binding Proteins Human genes 0.000 description 3
• 230000004568 DNA-binding Effects 0.000 description 3
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
• 101150074628 HLA-E gene Proteins 0.000 description 3
• 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 3
• 101000737793 Homo sapiens Cerebellar degeneration-related antigen 1 Proteins 0.000 description 3
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 3
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 3
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 3
• 108010065805 Interleukin-12 Proteins 0.000 description 3
• 108010002586 Interleukin-7 Proteins 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• 206010025323 Lymphomas Diseases 0.000 description 3
• 208000034578 Multiple myelomas Diseases 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 3
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 3
• 108091028664 Ribonucleotide Proteins 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 238000010459 TALEN Methods 0.000 description 3
• 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 3
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 125000000539 amino acid group Chemical group 0.000 description 3
• 229910052799 carbon Inorganic materials 0.000 description 3
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 238000005119 centrifugation Methods 0.000 description 3
• 208000029742 colonic neoplasm Diseases 0.000 description 3
• 238000010276 construction Methods 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• 108020001507 fusion proteins Proteins 0.000 description 3
• 102000037865 fusion proteins Human genes 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• 210000004408 hybridoma Anatomy 0.000 description 3
• 208000015181 infectious disease Diseases 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 238000004255 ion exchange chromatography Methods 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 230000003211 malignant effect Effects 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 201000006417 multiple sclerosis Diseases 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 210000000822 natural killer cell Anatomy 0.000 description 3
• 238000010647 peptide synthesis reaction Methods 0.000 description 3
• 102000040430 polynucleotide Human genes 0.000 description 3
• 108091033319 polynucleotide Proteins 0.000 description 3
• 239000002157 polynucleotide Substances 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 238000003127 radioimmunoassay Methods 0.000 description 3
• 238000003259 recombinant expression Methods 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 239000002336 ribonucleotide Substances 0.000 description 3
• 125000002652 ribonucleotide group Chemical group 0.000 description 3
• 235000004400 serine Nutrition 0.000 description 3
• 150000003384 small molecules Chemical class 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 3
• 230000006641 stabilisation Effects 0.000 description 3
• 238000011105 stabilization Methods 0.000 description 3
• 238000006467 substitution reaction Methods 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 238000012546 transfer Methods 0.000 description 3
• 238000013519 translation Methods 0.000 description 3
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 2
• 102000006942 B-Cell Maturation Antigen Human genes 0.000 description 2
• 108010008014 B-Cell Maturation Antigen Proteins 0.000 description 2
• 208000003950 B-cell lymphoma Diseases 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 102100027314 Beta-2-microglobulin Human genes 0.000 description 2
• 102100038078 CD276 antigen Human genes 0.000 description 2
• 101150013553 CD40 gene Proteins 0.000 description 2
• 102100035793 CD83 antigen Human genes 0.000 description 2
• 238000010453 CRISPR/Cas method Methods 0.000 description 2
• 101100112922 Candida albicans CDR3 gene Proteins 0.000 description 2
• 102100026548 Caspase-8 Human genes 0.000 description 2
• 102100035361 Cerebellar degeneration-related protein 2 Human genes 0.000 description 2
• 108010009685 Cholinergic Receptors Proteins 0.000 description 2
• 208000006332 Choriocarcinoma Diseases 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 101710096438 DNA-binding protein Proteins 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• 102100023721 Ephrin-B2 Human genes 0.000 description 2
• 239000004471 Glycine Substances 0.000 description 2
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 102100028966 HLA class I histocompatibility antigen, alpha chain F Human genes 0.000 description 2
• 101150118346 HLA-A gene Proteins 0.000 description 2
• 102210042925 HLA-A*02:01 Human genes 0.000 description 2
• 102210024049 HLA-A*03:01 Human genes 0.000 description 2
• 108010020515 HLA-A*68 antigen Proteins 0.000 description 2
• 108010091938 HLA-B7 Antigen Proteins 0.000 description 2
• 241000700721 Hepatitis B virus Species 0.000 description 2
• 208000005176 Hepatitis C Diseases 0.000 description 2
• 208000017604 Hodgkin disease Diseases 0.000 description 2
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 2
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 2
• 101000737796 Homo sapiens Cerebellar degeneration-related protein 2 Proteins 0.000 description 2
• 101000986080 Homo sapiens HLA class I histocompatibility antigen, alpha chain F Proteins 0.000 description 2
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 2
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 102000006992 Interferon-alpha Human genes 0.000 description 2
• 108010047761 Interferon-alpha Proteins 0.000 description 2
• 108010002352 Interleukin-1 Proteins 0.000 description 2
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 2
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 2
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
• 102000047918 Myelin Basic Human genes 0.000 description 2
• 101710107068 Myelin basic protein Proteins 0.000 description 2
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
• 238000005481 NMR spectroscopy Methods 0.000 description 2
• 108091005461 Nucleic proteins Proteins 0.000 description 2
• 108091093037 Peptide nucleic acid Proteins 0.000 description 2
• 102100036691 Proliferating cell nuclear antigen Human genes 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 108091034057 RNA (poly(A)) Proteins 0.000 description 2
• 241000193996 Streptococcus pyogenes Species 0.000 description 2
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 2
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
• 108091028113 Trans-activating crRNA Proteins 0.000 description 2
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 2
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 2
• 102000034337 acetylcholine receptors Human genes 0.000 description 2
• 101150063416 add gene Proteins 0.000 description 2
• 238000007792 addition Methods 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 238000001261 affinity purification Methods 0.000 description 2
• 108010081355 beta 2-Microglobulin Proteins 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 229910000389 calcium phosphate Inorganic materials 0.000 description 2
• 235000011010 calcium phosphates Nutrition 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 108091036078 conserved sequence Proteins 0.000 description 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• 238000002716 delivery method Methods 0.000 description 2
• 239000005547 deoxyribonucleotide Substances 0.000 description 2
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
• 239000003599 detergent Substances 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 238000004520 electroporation Methods 0.000 description 2
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
• 231100000221 frame shift mutation induction Toxicity 0.000 description 2
• 230000037433 frameshift Effects 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 210000004602 germ cell Anatomy 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000002998 immunogenetic effect Effects 0.000 description 2
• 238000000126 in silico method Methods 0.000 description 2
• 230000003902 lesion Effects 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 230000021633 leukocyte mediated immunity Effects 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 238000011068 loading method Methods 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 230000001394 metastastic effect Effects 0.000 description 2
• 206010061289 metastatic neoplasm Diseases 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 239000000178 monomer Substances 0.000 description 2
• 206010028417 myasthenia gravis Diseases 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
• 238000011176 pooling Methods 0.000 description 2
• 210000002307 prostate Anatomy 0.000 description 2
• 206010039073 rheumatoid arthritis Diseases 0.000 description 2
• 238000003118 sandwich ELISA Methods 0.000 description 2
• 239000007787 solid Substances 0.000 description 2
• 125000006850 spacer group Chemical group 0.000 description 2
• 238000010186 staining Methods 0.000 description 2
• 239000006228 supernatant Substances 0.000 description 2
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
• 238000010361 transduction Methods 0.000 description 2
• 230000026683 transduction Effects 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• 230000009261 transgenic effect Effects 0.000 description 2
• 238000012384 transportation and delivery Methods 0.000 description 2
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
• 241001529453 unidentified herpesvirus Species 0.000 description 2
• 229960005486 vaccine Drugs 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• KKVYYGGCHJGEFJ-UHFFFAOYSA-N 1-n-(4-chlorophenyl)-6-methyl-5-n-[3-(7h-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine Chemical compound N=1C=CC2=C(NC=3C(=CC=CN=3)C=3C=4N=CNC=4N=CN=3)C(C)=CC=C2C=1NC1=CC=C(Cl)C=C1 KKVYYGGCHJGEFJ-UHFFFAOYSA-N 0.000 description 1
• BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 1
• GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
• 108020005345 3' Untranslated Regions Proteins 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• 108020003589 5' Untranslated Regions Proteins 0.000 description 1
• 102100023990 60S ribosomal protein L17 Human genes 0.000 description 1
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 208000026872 Addison Disease Diseases 0.000 description 1
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
• 206010001935 American trypanosomiasis Diseases 0.000 description 1
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
• 101100393868 Arabidopsis thaliana GT11 gene Proteins 0.000 description 1
• 208000031504 Asymptomatic Infections Diseases 0.000 description 1
• 108010046304 B-Cell Activation Factor Receptor Proteins 0.000 description 1
• 102000007536 B-Cell Activation Factor Receptor Human genes 0.000 description 1
• 108010074708 B7-H1 Antigen Proteins 0.000 description 1
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 208000011691 Burkitt lymphomas Diseases 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• 102100025221 CD70 antigen Human genes 0.000 description 1
• 101100495352 Candida albicans CDR4 gene Proteins 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 102000012410 DNA Ligases Human genes 0.000 description 1
• 108010061982 DNA Ligases Proteins 0.000 description 1
• 230000007018 DNA scission Effects 0.000 description 1
• 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 108010031111 EBV-encoded nuclear antigen 1 Proteins 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 241000214054 Equine rhinitis A virus Species 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 102100031507 Fc receptor-like protein 5 Human genes 0.000 description 1
• 101150032879 Fcrl5 gene Proteins 0.000 description 1
• 241001523858 Felipes Species 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 102100035233 Furin Human genes 0.000 description 1
• 108090001126 Furin Proteins 0.000 description 1
• 206010018364 Glomerulonephritis Diseases 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 208000024869 Goodpasture syndrome Diseases 0.000 description 1
• 208000003807 Graves Disease Diseases 0.000 description 1
• 208000015023 Graves' disease Diseases 0.000 description 1
• 102210024048 HLA-A*01:01 Human genes 0.000 description 1
• 102220404671 HLA-A*11:01 Human genes 0.000 description 1
• 108010021727 HLA-A*24:02 antigen Proteins 0.000 description 1
• 102210041563 HLA-A*31:01 Human genes 0.000 description 1
• 108010026122 HLA-A*33 antigen Proteins 0.000 description 1
• 102220404670 HLA-A*33:01 Human genes 0.000 description 1
• 108010035452 HLA-A1 Antigen Proteins 0.000 description 1
• 108010013476 HLA-A24 Antigen Proteins 0.000 description 1
• 108010029526 HLA-A28 antigen Proteins 0.000 description 1
• 108010018475 HLA-A31 antigen Proteins 0.000 description 1
• 101150000578 HLA-B gene Proteins 0.000 description 1
• 102210009883 HLA-B*07:02 Human genes 0.000 description 1
• 102210024050 HLA-B*08:01 Human genes 0.000 description 1
• 102210024051 HLA-B*15:01 Human genes 0.000 description 1
• 102210042926 HLA-B*44:02 Human genes 0.000 description 1
• 102220436838 HLA-B*51 Human genes 0.000 description 1
• 102210024052 HLA-B*57:01 Human genes 0.000 description 1
• 108010028938 HLA-B45 antigen Proteins 0.000 description 1
• 101150035071 HLA-C gene Proteins 0.000 description 1
• 108010037618 HLA-C*08 antigen Proteins 0.000 description 1
• 108010062347 HLA-DQ Antigens Proteins 0.000 description 1
• 108010058597 HLA-DR Antigens Proteins 0.000 description 1
• 102000006354 HLA-DR Antigens Human genes 0.000 description 1
• 108010078473 HLA-E antigen Proteins 0.000 description 1
• 208000001204 Hashimoto Disease Diseases 0.000 description 1
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 1
• 101000690301 Homo sapiens Aldo-keto reductase family 1 member C4 Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 1
• 101000935587 Homo sapiens Flavin reductase (NADPH) Proteins 0.000 description 1
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
• 101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 description 1
• 101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 description 1
• 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 1
• 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 1
• 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 description 1
• 101000979735 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial Proteins 0.000 description 1
• 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 description 1
• 101000687346 Homo sapiens PR domain zinc finger protein 2 Proteins 0.000 description 1
• 101001116548 Homo sapiens Protein CBFA2T1 Proteins 0.000 description 1
• 101000739160 Homo sapiens Secretoglobin family 3A member 1 Proteins 0.000 description 1
• 101000662909 Homo sapiens T cell receptor beta constant 1 Proteins 0.000 description 1
• 101000662902 Homo sapiens T cell receptor beta constant 2 Proteins 0.000 description 1
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 1
• 101000795169 Homo sapiens Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
• 241000598436 Human T-cell lymphotropic virus Species 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010034143 Inflammasomes Proteins 0.000 description 1
• 102100025390 Integrin beta-2 Human genes 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
• 108020003285 Isocitrate lyase Proteins 0.000 description 1
• 208000003456 Juvenile Arthritis Diseases 0.000 description 1
• 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
• 101150069255 KLRC1 gene Proteins 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• 229930182816 L-glutamine Natural products 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 description 1
• 102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 description 1
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 108010091221 Lymphotoxin beta Receptor Proteins 0.000 description 1
• 108700005089 MHC Class I Genes Proteins 0.000 description 1
• 102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 description 1
• 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 description 1
• 101100404845 Macaca mulatta NKG2A gene Proteins 0.000 description 1
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
• 101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100381978 Mus musculus Braf gene Proteins 0.000 description 1
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 102100024975 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial Human genes 0.000 description 1
• 230000006051 NK cell activation Effects 0.000 description 1
• 102100022682 NKG2-A/NKG2-B type II integral membrane protein Human genes 0.000 description 1
• 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 description 1
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
• 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
• 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
• 102100021462 Natural killer cells antigen CD94 Human genes 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 101000610236 Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) Protein PatA Proteins 0.000 description 1
• 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 102100024885 PR domain zinc finger protein 2 Human genes 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 241000721454 Pemphigus Species 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102100037882 Perilipin-5 Human genes 0.000 description 1
• 208000031845 Pernicious anaemia Diseases 0.000 description 1
• 241001672814 Porcine teschovirus 1 Species 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 241001304248 Progne modesta Species 0.000 description 1
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 1
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 1
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 1
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 108010010974 Proteolipids Proteins 0.000 description 1
• 102000016202 Proteolipids Human genes 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 238000002123 RNA extraction Methods 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 102100037268 Secretoglobin family 3A member 1 Human genes 0.000 description 1
• 208000021386 Sjogren Syndrome Diseases 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 230000006052 T cell proliferation Effects 0.000 description 1
• 102100037272 T cell receptor beta constant 1 Human genes 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 1
• 101150002618 TCRP gene Proteins 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 241001648840 Thosea asigna virus Species 0.000 description 1
• 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
• 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
• 241000223109 Trypanosoma cruzi Species 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 1
• 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 description 1
• 101710178302 Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 description 1
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 1
• 102100022156 Tumor necrosis factor receptor superfamily member 3 Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 238000010306 acid treatment Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 238000007844 allele-specific PCR Methods 0.000 description 1
• 238000013103 analytical ultracentrifugation Methods 0.000 description 1
• 238000004873 anchoring Methods 0.000 description 1
• 230000006023 anti-tumor response Effects 0.000 description 1
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
• 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 239000013602 bacteriophage vector Substances 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000001772 blood platelet Anatomy 0.000 description 1
• 238000010504 bond cleavage reaction Methods 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 208000000594 bullous pemphigoid Diseases 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 239000004568 cement Substances 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 230000003196 chaotropic effect Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 208000019069 chronic childhood arthritis Diseases 0.000 description 1
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
• 238000002983 circular dichroism Methods 0.000 description 1
• 239000013599 cloning vector Substances 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 238000007906 compression Methods 0.000 description 1
• 230000006835 compression Effects 0.000 description 1
• 239000013256 coordination polymer Substances 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 230000016396 cytokine production Effects 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 238000002784 cytotoxicity assay Methods 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 201000001981 dermatomyositis Diseases 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 210000001163 endosome Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 229940088598 enzyme Drugs 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 230000004907 flux Effects 0.000 description 1
• 239000012737 fresh medium Substances 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 230000005251 gamma ray Effects 0.000 description 1
• 238000012239 gene modification Methods 0.000 description 1
• 210000000585 glomerular basement membrane Anatomy 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 210000003128 head Anatomy 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 102000054751 human RUNX1T1 Human genes 0.000 description 1
• 230000005934 immune activation Effects 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000003832 immune regulation Effects 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 230000007813 immunodeficiency Effects 0.000 description 1
• 238000003125 immunofluorescent labeling Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 230000004957 immunoregulator effect Effects 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 229960001388 interferon-beta Drugs 0.000 description 1
• 108010074108 interleukin-21 Proteins 0.000 description 1
• 201000002313 intestinal cancer Diseases 0.000 description 1
• 229940029329 intrinsic factor Drugs 0.000 description 1
• PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
• PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
• 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 238000012417 linear regression Methods 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 210000005210 lymphoid organ Anatomy 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 230000036210 malignancy Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 1
• 239000010445 mica Substances 0.000 description 1
• 229910052618 mica group Inorganic materials 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 229960004857 mitomycin Drugs 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 238000009126 molecular therapy Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
• 210000003739 neck Anatomy 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000010807 negative regulation of binding Effects 0.000 description 1
• 210000005170 neoplastic cell Anatomy 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 230000009871 nonspecific binding Effects 0.000 description 1
• 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 238000007747 plating Methods 0.000 description 1
• 208000005987 polymyositis Diseases 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 238000002818 protein evolution Methods 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• JRPHGDYSKGJTKZ-UHFFFAOYSA-K selenophosphate Chemical compound [O-]P([O-])([O-])=[Se] JRPHGDYSKGJTKZ-UHFFFAOYSA-K 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• 238000004513 sizing Methods 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 239000000243 solution Substances 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 229940076156 streptococcus pyogenes Drugs 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 231100000617 superantigen Toxicity 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 238000004885 tandem mass spectrometry Methods 0.000 description 1
• 101150095542 tap gene Proteins 0.000 description 1
• 238000002626 targeted therapy Methods 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 238000003151 transfection method Methods 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 108091007466 transmembrane glycoproteins Proteins 0.000 description 1
• 108010055094 transporter associated with antigen processing (TAP) Proteins 0.000 description 1
• 238000011282 treatment Methods 0.000 description 1
• 230000004565 tumor cell growth Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 244000052613 viral pathogen Species 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1